Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRAIN: Acetazolamide in Normal Pressure Hydrocephalus
NCT04975269Phase 2Completed
- Sponsor
- Akademiska sjukhuset
- Start
- Feb 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Idiopathic Normal Pressure Hydrocephalus (NPH) comparing Acetazolamide with Placebo (2 arms). Primary endpoint: Proportional change in gait function. Started Feb 2022; status: completed.
02
Drugs
acetazolamide
03
Conditions
Idiopathic Normal Pressure Hydrocephalus (NPH)
Beyond the preview
Go deeper on NCT04975269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04975269.